Institut Fur Molekulare und Klinische Ophthalmologie Basel

Institut Fur Molekulare und Klinische Ophthalmologie Basel is a research organisation in Basel, Switzerland that has taken part in 6 EU-funded projects since 2015, receiving €5.3M in EU funding and leading 3 as coordinator.

EU funding received€5.3M
EU projects6
As coordinator3
Running now2
First EU project2015
Latest project2026
CountrySwitzerland
EU registration (PIC)907055537
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut Fur Molekulare und Klinische Ophthalmologie Basel's own share of each project, not the project's full budget.

  • Horizon 2020€3.3M · 4 projects
  • Horizon Europe€2.0M · 2 projects

Projects

6 EU-funded projects, newest first. Institut Fur Molekulare und Klinische Ophthalmologie Basel led 3 of them as coordinator. Each links to the official record.

  • BaseVisionCoordinator

    Advancing therapeutic base editing for vision loss

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €2.0Mtheir share
  • MyoTreatAssociated partner

    Myopia - from genes and environment to cellular responses and treatment

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • HyVISPartner

    Hybrid synapse for vision

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €187ktheir share
  • HURETCoordinator

    The human retina at single cell resolution: functional architecture, disease mechanism and therapy development

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €2.5Mtheir share
  • ANTHROPOIDPartner

    Great ape organoids to reconstruct uniquely human development

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €461ktheir share
  • RETMUSCoordinator

    The interpretation of retinal activity by the visual thalamus.

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €171ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • artificial intelligence
  • biosphera
  • data processing
  • gene therapy
  • genetic engineering
  • glaucoma
  • implants
  • mutation
  • neurobiology
  • ophthalmology
  • pharmacology and pharmacy
  • physiology
  • planets
  • polymer sciences

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime